We are thrilled to announce that OncoDaily Medical Journal is now the official journal of the Immune Oncology Research Institute (IMMONC). This partnership is a major step forward in our shared mission to highlight the latest advancements and innovations in cancer immunotherapy globally. Together with IMMONC, we will provide a platform for publishing research and clinical developments, and expert insights, contributing to the rapidly evolving field of immune-oncology.

About IMMONC

The Immune Oncology Research Institute (IMMONC) is a non-profit research institution dedicated to improving cancer outcomes through impactful and inclusive research. IMMONC aims to benefit patients worldwide, regardless of their geographic location or socioeconomic status, by driving forward research that leads to better cancer treatments and increased access to clinical trials.

For more information, visit – IMMONC.